Section Arrow
ORGS.NASDAQ
- Orgenesis
(Financial Status)
Quotes are at least 15-min delayed:2024/04/25 19:27 EDT
Last
 0.504
+0.002 (+0.40%)
Day High 
0.5209 
Prev. Close
0.502 
1-M High
0.913 
Volume 
11.93K 
Bid
0.5
Ask
0.5208
Day Low
0.5 
Open
0.51 
1-M Low
0.3044 
Market Cap 
17.25M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.51 
20-SMA 0.54 
50-SMA 0.64 
52-W High 1.5 
52-W Low 0.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.91/-0.19
Enterprise Value
36.31M
Balance Sheet
Book Value Per Share
-0.61
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
530.00K
Operating Revenue Per Share
1.04
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PCSAProcessa Pharmaceuticals2.43+0.81+50.00%-- 
DNAGinkgo Bioworks Holdings0.7777-0.0681-8.05%-- 
JAGXJaguar Health0.17+0.0001+0.06%-- 
KTRAKintara Therapeutics0.158+0.0207+15.08%-- 
ATXIAvenue Therapeutics0.117+0.0227+24.07%-- 
Quotes are at least 15-min delayed:2024/04/25 19:27 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.